BRIEF published on 04/14/2026 at 09:05, 2 months 12 days ago MVISE AG définit une stratégie audacieuse d'acquisition et de développement Investissement Stratégique Marché Allemand Acquisition De Logiciels MVISE AG Achat Et Construction
BRIEF published on 04/14/2026 at 09:05, 2 months 12 days ago MVISE AG Sets Bold Buy & Build Strategy Strategic Investment Software Acquisition Germany Market MVISE AG Buy & Build
PRESS RELEASE published on 04/14/2026 at 09:00, 2 months 12 days ago Original-Research: mVISE AG (von NuWays AG): BUY mVISE AG announces negotiations to acquire minority stakes in three software-centric companies, signaling transformation into a Buy & Build platform. Potential for market leadership and revenue growth Acquisition Market Leadership MVISE AG Software-centric Companies Buy & Build Platform
BRIEF published on 04/13/2026 at 09:51, 2 months 13 days ago MVISE AG négocie trois investissements stratégiques Investissements Allemagne MVISE AG Leadership Sur Le Marché Sociétés De Logiciels
BRIEF published on 04/13/2026 at 09:51, 2 months 13 days ago MVISE AG Negotiates Three Strategic Investments Germany Investments Software Companies Market Leadership MVISE AG
PRESS RELEASE published on 04/13/2026 at 09:46, 2 months 13 days ago mVISE AG is in concrete negotiations regarding three investments mVISE AG in concrete negotiations for investments in three software-focused companies, aiming for German market leadership positions. Operational performance targets include annual EBITDA of EUR 1-1.5 million Negotiations Investments MVISE AG Software-focused Companies German Market Leadership
BRIEF published on 04/01/2026 at 13:34, 2 months 24 days ago MVISE AG Extends Convertible Bond to 2030 Investors Financial Performance Extension Convertible Bond MVISE AG
BRIEF published on 04/01/2026 at 13:34, 2 months 24 days ago MVISE AG prolonge l'échéance de son obligation convertible jusqu'en 2030 Performance Financière Investisseurs Extension Obligation Convertible MVISE AG
PRESS RELEASE published on 04/01/2026 at 13:29, 2 months 24 days ago mVISE AG successfully extends its 22/26 convertible bond until 2030 mVISE AG extends 22/26 convertible bond to 2030, aligning debt and equity interests. Bond terms amended with attractive 4.50% coupon for investors Convertible Bond Debt Equity Interests MVISE AG Amended Bond Terms
BRIEF published on 02/10/2026 at 09:05, 4 months 16 days ago MVISE AG Reports Strong Profitability Amid Strategic Sales Decline Profitability Software Development Recurring Revenues MVISE AG Strategic Sales Decline
Published on 06/26/2026 at 13:00, 25 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 11 hours 45 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 13 hours 55 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 14 hours 55 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/26/2026 at 13:00, 25 minutes ago Schweizer Electronic and Ascent Circuits Plan Strategic Indo-German PCB Cooperation
Published on 06/26/2026 at 12:18, 1 hour 6 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026
Published on 06/26/2026 at 11:30, 1 hour 55 minutes ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 06/26/2026 at 11:14, 2 hours 10 minutes ago EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 07:00, 6 hours 25 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 6 hours 25 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 40 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 18 hours 55 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
